Loading...
HomeMy Public PortalAbout4.13.2023 Statewide Opioid Settlement AGOStatewide Opioid Settlement Update Massachusetts Attorney General’s Office April 13, 2023 Agenda •Background •Finalized Statewide Settlements •New Statewide Settlements •Municipal Sign-On Process •Abatement Funds The Attorney General’s Investigations Key Findings: Opioid Manufacturers used unfair and deceptive sales tactics to aggressively promote prescription opioids, including through tens of thousands of in-person sales calls to Massachusetts prescribers, resulting in a flood of inappropriate prescriptions. Opioid Distributors failed to implement adequate suspicious order monitoring systems, ignored red flags, and shipped thousands of suspicious orders to pharmacies across the state. Pharmacies across the state dispensed opioid prescriptions without sufficient regard for their legitimacy, in violation of their corresponding responsibility. The Resulting Tragedy: This misconduct enabled and perpetuated vast increases in opioid over-dispensing and diversion, and multiplied the toll of substance use disorder, overdose, and death that the Commonwealth and its residents continue to suffer. From 2009 through September 2021, state records show that 18,061 Massachusetts residents died of opioid-related overdoses. More than 68% of those people –12,372 Massachusetts residents –filled prescriptions for Schedule II opioids written by Massachusetts prescribers. MA Opioid Settlement Overview Over $900 million in settlement funds for prevention, harm reduction, treatment, and recovery services. Entity Structure Payment Start Date Total Payment Amount McKinsey ORRF 2021 $13 million Johnson & Johnson and Distributors ORRF and Municipalities 2022 $525 million Teva, Allergen, CVS, Walgreens, and Walmart ORRF and Municipalities 2023 [projected] $421 million Finalized Statewide Opioid Settlements Finalized AGO settlements under which Massachusetts municipalities are eligible to receive direct payments in exchange for signing releases include: •McKesson, Cardinal, and AmerisourceBergen (the “Distributors”) •Johnson & Johnson (“J&J”) Nearly all Massachusetts cities and towns are participating in, and currently receiving funds under, these settlements. As of March 31, 2023, over $42 million has been paid to Massachusetts cities and towns from the Distributors and J&J settlements, and over $86 million has gone to the state’s Opioid Recovery and Remediation Fund (the “ORRF”). New Statewide Opioid Settlements The AGO has reached settlements in principle with the following entities: •Pharmacies: •CVS •Walgreens •Walmart •Manufacturers: •Allergan •Teva In order to receive payment under these settlements, Massachusetts cities and towns, as well as eligible special districts, must sign on to the settlements by April 18, 2023. Municipal Sign-On Process 1.Municipalities were sent participation forms and instructions for completing those forms by Rubris, the settlement administrator, on February 9, 2023. 2.Municipalities that would like to participate in the settlement agreements and receive payments must sign and return the forms to Rubris by April 18, 2023. 3.Please check with your municipalities to confirm that they have signed on to the settlements. If they have not done so, have them contact the AGO ASAP. Municipal Sign-On Process •Municipalities must sign and return a participation form for each settlement in which they would like to participate. •Note: •The Allergan and Teva settlements have a shared participation form. (“Will your subdivision or special district be signing the settlement participation forms for the Allergan and Teva Settlements at this time? Yes/No”) •Each of the other three settlements (CVS, Walgreens, and Walmart) have separate participation forms. •Forms submitted for prior settlements, such as the settlement with J&J, are not applicable to the five new settlements. •Prompt sign-on will ensure that Massachusetts and its municipalities receive the maximum amount of abatement funds from the settlements. Abatement Funds •Under the State-Subdivision Agreement, funds from statewide opioid settlements are allocated as follows: •40% to the state’s municipalities to expend on approved programs and strategies •60% to the state’s Opioid Recovery and Remediation Fund •Requires all funds to be used to supplement and strengthen resources for prevention, harm reduction, treatment, and recovery. •Requires annual reporting to EOHHS by municipalities that receive annual payments of $35,000. For municipalities falling below this threshold, a report is encouraged. •Draft annual municipal reporting form is submitted through a web-based reporting platform. •Municipalities are encouraged to pool resources and collaborate, including by leveraging existing shared services infrastructure: https://www.mass.gov/service-details/public-health-shared-services. Abatement Funds On the AGO’s website, you can find: 1.Answers to frequently asked questions. •https://www.mass.gov/info-details/frequently-asked-questions- about-the-ags-statewide-opioid-settlements 2.The maximum estimated annual distributions to municipalities if they choose to participate in the five new settlements. •https://www.mass.gov/lists/municipal-abatement-payments 3.The maximum estimated annual distributions to municipalities participating in the settlements with the Distributors and J&J. •https://www.mass.gov/lists/municipal-abatement-payments Questions If you have questions about the final statewide opioid settlements, the new statewide opioid settlements, the municipal sign-on process, or abatement funds, please contact the AGO at: MAOpioidSettlements@mass.gov